RPRD1A antibody (AA 231-312) (Cy5)
Quick Overview for RPRD1A antibody (AA 231-312) (Cy5) (ABIN913982)
Target
See all RPRD1A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 231-312
-
Predicted Reactivity
- Human,Mouse,Rat,Cow,Pig,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RPRD1A/P15RS
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- RPRD1A (Regulation of Nuclear Pre-mRNA Domain Containing 1A (RPRD1A))
-
Alternative Name
- RPRD1A
-
Background
-
Synonyms: Cyclin dependent kinase 2B inhibitor related protein, Cyclin dependent kinase inhibitor 2B related protein p15INK4B related protein, Cyclin dependent kinase inhibitor 2B related protein, Cyclin dependent kinase inhibitor related protein, Hypothetical protein FLJ10656, p15INK4B related protein, Putative uncharacterized protein P15RS, Regulation of nuclear pre mRNA domain containing 1A, RPRD1A, RPR1A_HUMAN.
Background: P15RS is upregulated in cells overexpressing cyclin-dependent kinase inhibitor p15(INK4b) (CDKN2B, MIM 600431) and may have a role in cell cycle regulation
Target
-